EFEMP2 significantly inhibits the invasion and metastasis of tumor cells and the process of epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin pathway in lung, bladder, and breast cancers (19–21). The gene discussed is EFEMP2; the disease is neoplasm.